Optec International, Inc. Receivables Turnover Ratio (GRMD), from the second quarter 2019 to the second quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Optec International, Inc.  (GRMD)
 

Optec International Accounts Receivables Turnover Ratio from the second quarter 2019 to the second quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Optec International, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2019 to a ratio of 0.54, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2019. Average receivable collection period, for the Optec International in Dec 31 2018 quarter, has decreased to 676 days, compared to 1921 days, in the Sep 30 2018 quarter.

If we take a look into Healthcare sector Optec International, Inc. achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Optec International, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GRMD Receivables Turnover Ratio (Dec 31 2018)
II. Quarter		 (Sep 30 2018)
I. Quarter		 (Jun 30 2018)
IV. Quarter		 (Mar 31 2018)
III. Quarter		 (Dec 31 2017)
II. Quarter
Y / Y Receivable Change -91.76 % -87.1 % - 664.46 % 2231.74 %
Y / Y Revenue Change - -83.89 % - -97.46 % -
Receivable Turnover Ratio (TTM) 0.54 0.19 1.12 1.1 1.65
GRMD's Total Ranking # # # # #
Accounts Receivable average collection period days 680 1922 326 331 222
Seq. Receivable Change 0 % - - -34.97 % 56.48 %
Seq. Revenue Change - 1.0987341938904E+17 % -100 % - -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





GRMD Company Profile • Back to GRMD Efficiency Comparisons • Compare GRMD Receivables Turnover Ratio to its Competitors

Financial Statements
Optec International's Accounts Receivable $ 0 Millions Visit GRMD's Balance sheet
Optec International's Sales TTM $ 0 Millions Visit GRMD's Income Statement
Sources of GRMD's Revenues Visit GRMD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GRMD's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GRMD's Growth Rates GRMD's Roa GRMD's Inventory Turnover Ratio GRMD's Dividend Comparisons
GRMD's Profitability Ratios GRMD's Roi GRMD's Asset Turnover Ratio GRMD's Dividend Growth
GRMD's Valuation Ratios GRMD's Roe GRMD's Financial Strength Ratios GRMD's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2018, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2018 Receivable at quarter ending Dec 31 2018
Vivus Inc  3.64 $ 65.062  Millions$ 17.899  Millions
Spectrum Pharmaceuticals Inc   3.63 $ 109.333  Millions$ 30.098  Millions
Jrsis Health Care Corp  3.58 $ 28.403  Millions$ 7.940  Millions
Immune Design Corp.  3.53 $ 2.196  Millions$ 0.621  Millions
Reshape Lifesciences Inc  3.36 $ 2.403  Millions$ 0.714  Millions
Apyx Medical Corp  3.36 $ 16.686  Millions$ 4.972  Millions
Amarin Corp Plcuk  3.35 $ 229.214  Millions$ 68.375  Millions
Altimmune inc   3.35 $ 10.569  Millions$ 3.155  Millions
Ani Pharmaceuticals Inc  3.31 $ 201.576  Millions$ 60.851  Millions
Edap Tms Sa  3.30 $ 43.885  Millions$ 13.310  Millions
Biocardia Inc   3.28 $ 0.625  Millions$ 0.191  Millions
Alimera Sciences Inc  3.28 $ 46.970  Millions$ 14.328  Millions
Surgalign Holdings Inc   3.22 $ 139.710  Millions$ 43.410  Millions
Ethema Health Corporation   3.19 $ 0.433  Millions$ 0.136  Millions
Macrogenics Inc   3.18 $ 60.121  Millions$ 18.918  Millions
American Cryostem Corporation  3.14 $ 0.680  Millions$ 0.216  Millions
Sinovac Biotech Ltd  3.08 $ 229.650  Millions$ 74.464  Millions
Varian Medical Systems Inc   3.08 $ 2,981.600  Millions$ 967.425  Millions
Flexion Therapeutics Inc   3.07 $ 22.524  Millions$ 7.344  Millions
Eagle Pharmaceuticals inc   3.07 $ 213.312  Millions$ 69.570  Millions
Sangui Biotech International Inc  3.00 $ 0.077  Millions$ 0.026  Millions
Invo Fertility Inc   2.98 $ 0.494  Millions$ 0.166  Millions
Cellular Biomedicine Group Inc   2.98 $ 0.224  Millions$ 0.075  Millions
Viveve Medical Inc   2.97 $ 18.517  Millions$ 6.234  Millions
Horizon Therapeutics Public Limited Company  2.90 $ 1,207.570  Millions$ 415.932  Millions
Intelgenx Technologies Corp   2.86 $ 1.824  Millions$ 0.637  Millions
Emmaus Life Sciences Inc   2.86 $ 1.581  Millions$ 0.552  Millions
Abeona Therapeutics Inc   2.85 $ 0.388  Millions$ 0.136  Millions
Cardiff Oncology Inc   2.83 $ 0.378  Millions$ 0.134  Millions
Zyla Life Sciences  2.83 $ 30.353  Millions$ 10.728  Millions

Date modified: 2026-06-22T16:30:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.